The sudden and unexpected death of a female-to-male transsexual patient

Journal of Forensic and Legal Medicine

Volumn 14, Issue 6, 2007, Pages 382-386

  Inoue, Hiromasa ^a   Nishida, Naoki ^b   Ikeda, Noriaki ^c   Tsuji, Akiko ^c   Kudo, Keiko ^c   Hanagama, Masakazu ^a   Nata, Masayuki ^a  

^a MIE UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b AKITA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^c KYUSHU UNIVERSITY   (Japan)

Author keywords

Female to male; Ischemic heart disease; Sudden death; Testosterone; Transsexualism

Indexed keywords

TESTOSTERONE ENANTATE;

ADULT; ARTICLE; AUTOPSY; CASE REPORT; CAUSE OF DEATH; CORONARY ARTERY ATHEROSCLEROSIS; CORONARY ARTERY DISEASE; CORONARY ARTERY OBSTRUCTION; DISEASE EXACERBATION; FEMALE; FEMALE TO MALE TRANSSEXUAL; HEART MUSCLE FIBROSIS; HEART MUSCLE NECROSIS; HEART VENTRICLE HYPERTROPHY; HORMONE SUBSTITUTION; HUMAN; ISCHEMIC HEART DISEASE; SUDDEN DEATH;

ADULT; ANDROGENS; CORONARY STENOSIS; DEATH, SUDDEN; FEMALE; FORENSIC PATHOLOGY; HORMONE REPLACEMENT THERAPY; HUMANS; HYPERTROPHY, LEFT VENTRICULAR; INJECTIONS, INTRAMUSCULAR; MYOCARDIAL CONTRACTION; MYOCARDIAL ISCHEMIA; MYOCARDIUM; NECROSIS; TESTOSTERONE; TRANSSEXUALISM;

EID: 34447284977     PISSN: 1752928X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jcfm.2006.07.012     Document Type: Article

References (25)

1. Haraldsen I.R., and Dahl A.A. Symptom profiles of gender dysphoric patients of transsexual type compared to patients with personality disorders and healthy adults. Acta Psychiat Scand 102 (2000) 276-281
2. Michel A., Mormont C., and Legros J.J. A psycho-endocrinological overview of transsexualism. Eur J Endocrinol 145 (2001) 365-376
3. Moore E., Winsniewski A., and Dobs A. Endocrine treatment of transsexual people: A review of treatment regimens, outcomes, and adverse effects. J Clin Endocrinol Metab 88 (2003) 3467-3473
4. Michel A., Ansseau M., Legros J.J., Pitchot W., and Mormont C. The transsexual: What about the future?. Eur Psychiat 17 (2002) 353-362
5. Futterweit W. Endocrine therapy of transsexualism and potential complications of long-term treatment. Arch Sex Behav 27 (1998) 209-226
6. Asscheman H., Gooren L.J., and Eklund P.L. Mortality and morbidity in transsexual patients with cross-gender hormone treatment. Metabolism 38 (1989) 869-873
7. Levy A., Crown A., and Reid R. Endocrine intervention for transsexuals. Clin Endocrinol 59 (2003) 409-418
8. Giltay E.J., Toorians A.W., Sarabdjitsingh A.R., de Vries N.A., and Gooren L.J. Established risk factors for coronary heart disease are unrelated to androgen-induced baldness in female-to-male transsexuals. J Endocrinol 180 (2004) 107-112
9. Phillips G.B. Is atherosclerosis cardiovascular disease an endocrinological disorder? The estrogen-androgen paradox. J Clin Endocrinol Metab 90 (2005) 2708-2711
10. von Eckardstein A., and Wu F.C. Testosterone and atherosclerosis. Growth Horm IGF Res 13 (2003) S72-S84
11. Sheehan M.T. Polycystic ovarian syndrome: Diagnosis and management. Clin Med Res 2 (2004) 13-27
12. Ehrmann D.A. Polycystic ovary syndrome. N Engl J Med 352 (2005) 1223-1236
13. Wu F.C., and von Eckardstein A. Androgens and coronary artery disease. Endocr Rev 24 (2003) 183-217
14. Bruck B., Brehme U., Gugel N., et al. Gender-specific differences in the effects of testosterone and estrogen on the development of atherosclerosis in rabbits. Arterioscler Thromb Vasc Biol 17 (1997) 2192-2199
15. Rosano G.M.C., Leonardo F., Pagnotta P., et al. Acute anti-ischemic effect of testosterone in men with coronary artery disease. Circulation 99 (1999) 1666-1670
16. Malkin C.J., Pugh P.J., Jones T.H., and Channer K.S. Testosterone for secondary prevention in men with ischemic heart disease?. Q J M 96 (2003) 521-529
17. Callies F., Strömer H., Schwinger R.H., et al. Administration of testosterone is associated with a reduced susceptibility to myocardial ischemia. Endocrinology 144 (2003) 4478-4483
18. Catellier M.J., Chua G.T., Youmans G., and Waller B.F. Calcific deposits in the heart. Clin Cardiol 13 (1990) 287-294
19. Lockard V.G., and Bloom S. Morphologic features and nuclide composition of infarction-associated cardiac myocyte mineralization in humans. Am J Pathol 139 (1991) 565-572
20. Cotran R.S., Kumar V., and Collins T. Robbins pathologic basis of disease. Sixth ed. (1999), Saunders, Philadelphia
21. Nishida N., Ikeda N., Kudo K., Tsuji A., and Kiyoshima A. Forensic significance of conduction system abnormalities as a precise cause of accidental death. Int J Legal Med 116 (2002) 344-349
22. Nishida N., Ikeda N., Esaki R., Kudo K., and Tsuji A. Conduction system abnormalities in alcoholics with asymptomatic valvular disease who suffer sudden death. Legal Med 5 (2003) 212-219
23. Luke J.L., Farb A., Virmani R., and Sample R.H.B. Sudden cardiac death during exercise in a weight lifting using anabolic androgenic steroids: Pathological and toxicological finding. J Forensic Med 35 (1990) 1441-1447
24. George C.H., Higgs G.V., and Lai A. Ryanodine receptor mutations associated with stress-induced ventricular tachycardia mediate increased calcium release in stimulated cardiomyocytes. Circ Res 93 (2003) 531-540
25. Lehnart S.E., Werren X.H.T., Laitinen P.J., et al. Sudden death in familial polymorphic ventricular tachycardia associated with calcium release channel (ryanodine receptor) leak. Circulation 109 (2004) 3208-3214